Perbedaan Sinergi Multi Lestarindo Tbk. dan Tempo Scan Pacific Tbk.: Sinergi Multi Lestarindo Tbk. diperdagangkan di Rp144 (kapitalisasi pasar 344,57 M, volume 24 jam 9,46 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 33,9× kapitalisasi pasar Sinergi Multi Lestarindo Tbk., dan Sinergi Multi Lestarindo Tbk. lebih aktif diperdagangkan (9,46 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| SMLE | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 344,57 M | 11,68 T |
Volume | 9,46 jt | 429,7 rb |
Lot | 94,62 rb | 4,3 rb |
Perputaran | 1,36 M | 1,11 M |
Harga Rata-rata | 143,3 | 2.591,65 |
Nilai Transaksi | 1,36 M | 1,11 M |
Harga Ekuilibrium Indikatif | 144 | 2.580 |
Volume Ekuilibrium Indikatif | 140 | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Selengkapnya di halaman SMLE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →